Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
-1.78%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$4.08B
AUM Growth
+$662M
(+19%)
Cap. Flow
+$820M
Cap. Flow
% of AUM
20.11%
Top 10 Holdings %
Top 10 Hldgs %
12.58%
Holding
2,179
New
458
Increased
535
Reduced
444
Closed
446
Top Buys
| 1 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$46M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$41.1M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$32.6M |
| 5 |
VMW
VMware, Inc
VMW
|
+$32.6M |
Top Sells
| 1 |
Energy Select Sector SPDR Fund
XLE
|
+$37.7M |
| 2 |
RTLR
Rattler Midstream LP Common Units
RTLR
|
+$19.2M |
| 3 |
Stryker
SYK
|
+$16M |
| 4 |
HCA Healthcare
HCA
|
+$13.9M |
| 5 |
Warner Bros
WBD
|
+$13.4M |
Sector Composition
| 1 | Technology | 18.47% |
| 2 | Financials | 16.95% |
| 3 | Healthcare | 13.13% |
| 4 | Industrials | 11.3% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
OptimizeRx
OPRX
$326M
| $502K | 0.01% |
+33,879
| New | +$502K |
|
1102
Pliant Therapeutics
PLRX
$104M
| $501K | 0.01% |
+23,976
| New | +$501K |
|
|
QUOT
1103
DELISTED
Quotient Technology Inc
QUOT
| $500K | 0.01% |
216,497
-19,475
| -8% | -$45K |
|
1104
Kymera Therapeutics
KYMR
$3.11B
| $498K | 0.01% |
22,863
-18,449
| -45% | -$402K |
|
|
SNRH
1105
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
| $497K | 0.01% |
50,000
| – | – |
|
1106
EyePoint Pharmaceuticals
EYPT
$934M
| $496K | 0.01% |
62,759
+15,675
| +33% | +$124K |
|
1107
Peoples Bancorp
PEBO
$1.09B
| $495K | 0.01% |
17,111
+7,330
| +75% | +$212K |
|
1108
N-able
NABL
$1.53B
| $493K | 0.01% |
53,376
+12,740
| +31% | +$118K |
|
1109
Omeros
OMER
$291M
| $493K | 0.01% |
156,652
-2,253
| -1% | -$7.09K |
|
1110
Iron Mountain
IRM
$28.8B
| $491K | 0.01% |
+11,163
| New | +$491K |
|
1111
Western Alliance Bancorporation
WAL
$9.8B
| $489K | 0.01% |
+7,442
| New | +$489K |
|
1112
Vanguard FTSE Europe ETF
VGK
$26.9B
| $488K | 0.01% |
10,580
-29,385
| -74% | -$1.36M |
|
1113
Vertiv
VRT
$52.2B
| $488K | 0.01% |
50,200
-22,846
| -31% | -$222K |
|
1114
NNN REIT
NNN
$8.06B
| $487K | 0.01% |
+12,217
| New | +$487K |
|
|
CELL
1115
DELISTED
PhenomeX Inc. Common Stock
CELL
| $487K | 0.01% |
170,170
+35,493
| +26% | +$102K |
|
1116
Accuray
ARAY
$175M
| $485K | 0.01% |
233,156
+1,682
| +0.7% | +$3.5K |
|
1117
Coca-Cola Consolidated
COKE
$10.5B
| $485K | 0.01% |
+11,780
| New | +$485K |
|
1118
BlueLinx
BXC
$628M
| $484K | 0.01% |
7,796
-826
| -10% | -$51.3K |
|
1119
Keysight
KEYS
$29.3B
| $484K | 0.01% |
+3,075
| New | +$484K |
|
1120
Prosperity Bancshares
PB
$6.4B
| $484K | 0.01% |
7,261
+3,611
| +99% | +$241K |
|
1121
Skillsoft
SKIL
$117M
| $484K | 0.01% |
13,232
+9,245
| +232% | +$338K |
|
1122
Keros Therapeutics
KROS
$636M
| $483K | 0.01% |
12,829
+636
| +5% | +$23.9K |
|
1123
Cato Corp
CATO
$89.6M
| $482K | 0.01% |
50,526
| – | – |
|
1124
ATN International
ATNI
$235M
| $480K | 0.01% |
12,449
+5,686
| +84% | +$219K |
|
1125
Esperion Therapeutics
ESPR
$524M
| $479K | 0.01% |
71,444
+25,547
| +56% | +$171K |
|